Detalhe da pesquisa
1.
The effect of antimalarials on the safety and persistence of treatment with biologic agents or Janus kinase inhibitors in rheumatoid arthritis.
Rheumatology (Oxford)
; 63(2): 456-465, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37216912
2.
Serum soluble mediators as prognostic biomarkers for morbidity, disease outcome, and late-relapsing hepatitis in yellow fever patients.
Clin Immunol
; 251: 109321, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37019421
3.
Exposure to air pollution as an environmental determinant of how Sjögren's disease is expressed at diagnosis.
Clin Exp Rheumatol
; 41(12): 2448-2457, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38019154
4.
Influence of exposure to climate-related hazards in the phenotypic expression of primary Sjögren's syndrome.
Clin Exp Rheumatol
; 41(12): 2437-2447, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38019164
5.
Participating as a research team during the COVID-19 pandemic benefits mental health of undergraduate medical students in Brazil.
Psychol Health Med
; 28(6): 1441-1449, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331176
6.
Parotid gland swelling in primary Sjögren's syndrome: activity and other sialadenosis causes.
Rheumatology (Oxford)
; 61(7): 2987-2992, 2022 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34718449
7.
Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies.
Rheumatology (Oxford)
; 62(1): 243-255, 2022 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35385104
8.
Safety and efficacy of SARS-CoV-2 vaccination in 1237 patients with primary Sjögren syndrome.
Clin Exp Rheumatol
; 40(12): 2290-2297, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441656
9.
Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.
Clin Exp Rheumatol
; 40(7): 1258-1266, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34251312
10.
Health-related quality of life and costs in Sjögren's syndrome.
Rheumatology (Oxford)
; 60(6): 2588-2601, 2021 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30770918
11.
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients.
Rheumatology (Oxford)
; 60(6): 2946-2957, 2021 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33316070
12.
Post-COVID-19 syndrome in patients with primary Sjögren's syndrome after acute SARS-CoV-2 infection.
Clin Exp Rheumatol
; 39 Suppl 133(6): 57-65, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34874821
13.
Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium.
Clin Exp Rheumatol
; 39 Suppl 133(6): 166-174, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34919044
14.
Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome.
Rheumatology (Oxford)
; 59(9): 2350-2359, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31873754
15.
Acinar adipose tissue infiltration in salivary gland biopsy is associated with kynurenines-Interferon-γ pathway inflammation biomarkers.
Clin Exp Rheumatol
; 38 Suppl 126(4): 27-33, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33095140
16.
Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies.
Clin Exp Rheumatol
; 38 Suppl 126(4): 85-94, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33095152
17.
Incidence of Infectious Adverse Events in Patients With Rheumatoid Arthritis and Spondyloarthritis on Biologic Drugs-Data From the Brazilian Registry for Biologics Monitoring.
J Clin Rheumatol
; 26(2): 73-78, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32073519
18.
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients.
Clin Exp Rheumatol
; 37 Suppl 118(3): 97-106, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31464664
19.
Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sjögren's syndrome: a randomized-controlled trial.
Rheumatol Int
; 39(2): 227-238, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30604204
20.
Do antimalarials protect against damage accrual in primary Sjögren's syndrome? Results from a Latin-American retrospective cohort.
Clin Exp Rheumatol
; 36 Suppl 112(3): 182-185, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29745873